Microvascular decompression after gamma knife surgery for trigeminal neuralgia: intraoperative findings and treatment

Andrew G Shetter1, Joseph M Zabramski, Burton L Speiser

  • 1Division of Neurological Surgery and Pediatric Oncology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix, Arizona 85013, USA. neuropub@chw.edu

Journal of Neurosurgery
|January 25, 2005
PubMed
Abstract

Insights

Trigeminal microvascular decompression (MVD) is a viable treatment option for trigeminal neuralgia patients experiencing recurrence after gamma knife surgery (GKS). Prior GKS does not increase surgical difficulty or negatively impact MVD outcomes.

Area of Science:

  • Neurosurgery
  • Neurology

Background:

  • Gamma knife surgery (GKS) is a treatment for trigeminal neuralgia, but recurrence can occur.
  • Trigeminal microvascular decompression (MVD) is an alternative surgical option.

Purpose of the Study:

  • To evaluate if prior gamma knife surgery (GKS) affects the outcomes of trigeminal microvascular decompression (MVD).

Main Methods:

  • Six patients with trigeminal neuralgia recurrence post-GKS underwent MVD via retrosigmoid craniotomy.
  • Patients had received one or two GKS sessions.
  • Surgical findings revealed no significant technical difficulties related to prior GKS.

Main Results:

  • Five out of six patients achieved pain relief after MVD.
  • One patient experienced improvement but required continued medication.
  • No increased surgical difficulty was noted despite prior GKS.

Conclusions:

  • Trigeminal MVD is technically feasible and effective in patients with a history of GKS.
  • Success rates for MVD following GKS appear comparable to standard MVD procedures.
  • GKS is not a barrier to future MVD if pain recurs.

Related Concept Videos